Neuropharmacological Aspects of the Neural Control of Prolactin Secretion

  • James A. Clemens
Part of the Current topics in Molecular Endocrinology book series (CTME, volume 3)


In recent years, an increasing number of studies have appeared in which neuropharmacological agents were used in attempts to clarify which of the putative neurotransmitters are involved in the control of prolactin secretion. Some of the more recently developed drugs and pharmacological agents can be expected to demonstrate a high degree of specificity if used judiciously. The use of these agents in neuroendocrine studies has led to the identification of several neurotransmitters that are involved in the control of prolactin secretion. Few reviews have been totally devoted to the effects of pharmacological agents on prolactin secretion, therefore, a few aspects of the neuropharmacology of prolactin control are considered in some detail, and integration of data from a variety of sources is attempted.


Serum Prolactin Prolactin Secretion Serum Prolactin Level Prolactin Release Serotonin Neuron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ben-David, M., Davon, A., Benveniste, R., Weller, C.P. and Sulman, F.G. (1971) J. Endocrinol. 50, 599–606.PubMedCrossRefGoogle Scholar
  2. 2.
    Bertilsson, L., Koslow, S. and Costa, E. (1975) Brain Research 91, 348–350.PubMedCrossRefGoogle Scholar
  3. 3.
    Besser, G.M., Parke, L., Edwards, C.R.W., Forsyth, I.A. and McNeilly, A.S. (1972) Brit. Med. J. 3 (5828), 669–672.PubMedCrossRefGoogle Scholar
  4. 4.
    BrunDelRe, R., del Pozo, E., de Grandi, P., Friesen, H., Hinselmann, M. and Wyss, H. (1973) Ob. Gyn. 41, 884–890.Google Scholar
  5. 5.
    Caligaris, L. and Taleisnik, S. (1974) J. Endocrinol. 62, 25–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Cassady, J.M., Li, G., Spitzner, E., Floss, H. and Clemens, J.A. (1974) J. Med. Chem. 17, 300–307.PubMedCrossRefGoogle Scholar
  7. 7.
    Chen, H. J. and Meites, J. (1975) Endocrinology 96, 10–14.PubMedCrossRefGoogle Scholar
  8. 8.
    Clemens, J.A., Smalstig, E. B and Sawyer, B.D. (1974) Psychopharmacologia 40, 123–127.PubMedCrossRefGoogle Scholar
  9. 9.
    DelPozo, E., Friesen, H. and Burmeister, P. (1973) Schweig. Med. Wschr. 103, 847–848.Google Scholar
  10. 10.
    DelPozo, E., Brun del Re, R., Varga, L. and Friesen, H. (1972) J. Clin. Endocrinol. Metab. 35, 768–771.CrossRefGoogle Scholar
  11. 11.
    Dickerman, S., Clark, J., Dickerman, E. and Meites, J. (1972) Neuroendocrinology 9, 332–340.PubMedCrossRefGoogle Scholar
  12. 12.
    Donoso, A.O., Bishop, W., Fawcett, C.P., Krulich, L. and McCann, S.M. (1971) Endocrinology 89, 774–784.PubMedCrossRefGoogle Scholar
  13. 13.
    Dupont, A. and Redding, T.W. (1975) Program of the 57th Meeting of the Endocrine Society, New York, Abstract No. 85.Google Scholar
  14. 14.
    Ferrini, R. and Miragoli A (1972) Pharmacol. Res. Commun. 4, 347–352.CrossRefGoogle Scholar
  15. 15.
    Fuller, R. W., and Snoddy, H. D. (1974) Neuropharmacology 13, 85–90.PubMedCrossRefGoogle Scholar
  16. 16.
    Greibrokk, T., Currie, B.L., Johnansson, K.N.G., Hansen, J.J., Folkers, K. and Bowers, C. Y. (1974) Biochem. Biophys. Res. Commun. 59, 704–709.PubMedCrossRefGoogle Scholar
  17. 17.
    Handwerger, S., Plank, J.W., Lebowitz, H. E., Bivens, C. H. and Feldman, J. U. (1975) Horm. Metab. Res. 7, 214–216.CrossRefGoogle Scholar
  18. 18.
    Harvey, J. A., McMaster, S.E. and Yunger, L.M. (1975) Science 187, 841–843.PubMedCrossRefGoogle Scholar
  19. 19.
    Kambari, I. A., Mical, R.S. and Porter A (1971) Endocrinology 88, 1288–1293.CrossRefGoogle Scholar
  20. 20.
    Kato, Y., Nakai, Y., Imura, H., Chihara, K. and Ohgo, S. (1974) J. Clin. Endocrinol. Metab. 38, 695–697.PubMedCrossRefGoogle Scholar
  21. 21.
    Kleinberg, D.L., Noel, G.L. and Frantz, A.G. (1971) J. Clin. Endocrinol. Metab. 33, 873–876.CrossRefGoogle Scholar
  22. 22.
    Koch, Y, Lu, K.H. and Meites, J. (1970) Endocrinology 87, 673–675.PubMedCrossRefGoogle Scholar
  23. 23.
    Kordon, E., Blake, C.A., Terkel, J. and Sawyer, C. H. (1973) Neuroendocrinology 13, 213–223.PubMedCrossRefGoogle Scholar
  24. 24.
    Lal, S., Sourkes, T. L., Misseala, K. and Belendkink, G. (1972) Europ. J. Pharmacol. 20, 71–80.CrossRefGoogle Scholar
  25. 25.
    Lawson, D.M. and Gala, R.R. (1975) Endocrinology 96, 313–318.PubMedCrossRefGoogle Scholar
  26. 26.
    Lemberger, L., Crabtree, R., Clemens, J., Dyke, R. and Woodburne A (1974) J. Clin. Endocrinol. Metab. 39, 579–584.PubMedCrossRefGoogle Scholar
  27. 27.
    Lu, K. H., Amenomori, Y., Chen, C. L. and Meites, J. (1970) Endocrinology 87, 667–672.PubMedCrossRefGoogle Scholar
  28. 28.
    Lu, K. H. and Meites, J. (1971) Proc. Soc. Exp. Biol. Med. 137, 480–483.Google Scholar
  29. 29.
    MacLeod, R. M. and Lehmeyer, J. E. (1974) Endocrinology 94, 1077–1085.PubMedCrossRefGoogle Scholar
  30. 30.
    Malven, P. R. and Hoge, W. R. (1971) Endocrinology 88, 445–449.PubMedCrossRefGoogle Scholar
  31. 31.
    Martin, J. B., Lai, S., Tolis, G. and Friesen, H. (1974) J. Clin. Endocrinol. Metab. 39, 180–182.PubMedCrossRefGoogle Scholar
  32. 32.
    Mayer, P. and Schütze, E. (1973) Experentia 29, 484–485.CrossRefGoogle Scholar
  33. 33.
    Nagasawa, H. and Meites, J.(1970) Proc. Soc. Exp. Biol. Med. 135, 469–472.PubMedGoogle Scholar
  34. 34.
    Nicoll, C.S., Yaron, Z., Nutt, N. and Daniels, E. (1970) Biology of Reproductive 5, 59–66.Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • James A. Clemens
    • 1
  1. 1.The Lilly Research Laboratories (Eli Lilly and Co.)IndianapolisUSA

Personalised recommendations